FAST NEWS: Simcere gets exclusive rights to innovative influenza drug
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced Tuesday that it has signed a deal giving it exclusive commercialization rights for treatment of influenza indications using the innovative drug ADC189 from Jiaxing…
Recent Articles
RELATED ARTICLES
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK -
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK
-
Clinical trials come up short again for Alphamab Oncology
9966.HK
-
Everest reaches new heights on growing drug sales
1952.HK
- InSilico seeks IPO boost to get AI drugs over the line
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
